— All-cause and cancer-related mortality higher with aspirin; so were bleeding events
Daily aspirin not only failed to help generally healthy older individuals reduce their risk of disability-free survival and cardiovascular disease in the placebo-controlled ASPREE trial, it also appeared to raise overall mortality and particularly death from cancer.